Zentalis Pharmaceuticals (ZNTL) Interest & Investment Income (2019 - 2026)
Zentalis Pharmaceuticals' quarterly Interest & Investment Income came in at $2.6 million in Q1 2026, up 198.76% year-on-year from $877969.5 in Q1 2025, and little changed quarter-over-quarter from $2.6 million in Q4 2025.
Zentalis Pharmaceuticals has reported Interest & Investment Income for 8 years, with the latest figure at $2.6 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 198.76% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $21.5 million (up 277.43% YoY), and the FY2025 full-year result was $16.2 million, down 36.52% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.6 million, roughly flat from $2.6 million in the prior quarter.
- The five-year high for Interest & Investment Income was $34.9 million in Q1 2024, with the low at -$22.9 million in Q2 2024.
- Average Interest & Investment Income over 5 years is $4.3 million, with a median of $3.2 million recorded in 2022.
- Year-over-year, Interest & Investment Income surged 3572.73% in 2022 and slumped 613.66% in 2024.
- Tracing ZNTL's Interest & Investment Income over 5 years: stood at $3.2 million in 2022, then soared by 111.88% to $6.8 million in 2023, then plunged by 68.28% to $2.2 million in 2024, then gained by 20.58% to $2.6 million in 2025, then grew by 0.15% to $2.6 million in 2026.
- The last three Interest & Investment Income figures came in at $2.6 million (Q1 2026), $2.6 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - | 2.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.62 Mn |
| Dec 31, 2025 | 2.62 Mn |
| Sep 30, 2025 | 7.04 Mn |
| Jun 30, 2025 | 9.18 Mn |
| Mar 31, 2025 | -2.66 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | 11.25 Mn |
| Jun 30, 2024 | -22.86 Mn |
| Mar 31, 2024 | 34.95 Mn |
| Dec 31, 2023 | 6.85 Mn |
| Sep 30, 2023 | 7.21 Mn |
| Jun 30, 2023 | 4.45 Mn |
| Mar 31, 2023 | 4.11 Mn |
| Dec 31, 2022 | 3.23 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 424,000.00 |
| Mar 31, 2022 | 426,000.00 |
| Dec 31, 2021 | 88,000.00 |
| Sep 30, 2021 | 99,000.00 |
| Jun 30, 2021 | 115,000.00 |
| Mar 31, 2021 | 99,000.00 |
| Dec 31, 2020 | 315,000.00 |
| Sep 30, 2020 | 120,000.00 |
| Jun 30, 2020 | 84,000.00 |
| Mar 31, 2020 | 164,000.00 |
| Dec 31, 2019 | 359,000.00 |
| Sep 30, 2019 | 12,000.00 |
| Jun 30, 2019 | 49,000.00 |
| Mar 31, 2019 | 62,000.00 |